Doctor profile · Federal record
Dr. Beata Rydzik, MD
Dermatology Physician (CMS: Dermatology) · Dermatology Physician · Clinical & Laboratory Dermatological Immunology Physician · Clinical & Laboratory Dermatological Immunology Physician · Procedural Dermatology Physician · Procedural Dermatology Physician · Dermatopathology Physician · Dermatopathology Physician · Portland, OR
- NPI 1457357576
- Accepts Medicare
- MIPS 90.5 / 100 · 2023
- 22 yrs in practice
- Licensed in 2 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
9427 Sw Barnes RD, Suite 495
Portland, OR 972256652
(503) 297-3440
fax (503) 297-4584
Credentials & registration
- NPI registered
- June 2005 — 21 yrs on file
- Profile last updated
- June 13, 2012
- Year of graduation
- 2004 — 22 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (2)
- Oregon #MD25039 · Washington #MD00043352
- Medicaid
- OR #234458
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457357576. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,604
Distinct HCPCS
10
Medicare allowed
$93,530
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J7345 |
Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | 4,800 | 15 | $2 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 241 | 204 | $132 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 166 | 29 | $7 | |
11102 |
Biopsy of related skin growth, first growth | 112 | 101 | $89 | |
17110 |
Destruction of skin growth, 1-14 growths | 54 | 52 | $112 | |
11103 |
Biopsy of related skin growth, each additional growth | 53 | 32 | $54 | |
17000 |
Destruction of precancer skin growth, 1 growth | 44 | 41 | $47 | |
96574 |
Application of light with debridement to destroy precancer skin growth | 43 | 30 | $307 | |
J7308 |
Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 27 | 15 | $385 | |
11301 |
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm | 18 | 16 | $113 |
In context: peer comparison
Among 15 peers in this city , average services per provider: 168. This provider delivers 33× the peer median.Open Payments
Industry payments received
All-time total
$662
Transactions
15
Manufacturers
7
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $166.40 | |
| Janssen Biotech, Inc. | 5 | $145.74 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $130.93 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $111.69 | |
| PFIZER INC. | 1 | $78.00 | |
| Arcutis Biotherapeutics, Inc. | 1 | $16.25 | |
| Amgen Inc. | 1 | $13.35 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
622
Patients
373
Total drug cost
$22,891
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 85 | 59 | $3,847 |
| Doxycycline Hyclate | Generic | 85 | 27 | $2,867 |
| Minoxidil | Generic | 62 | 20 | $629 |
| Mupirocin | Generic | 61 | 50 | $554 |
| Fluorouracil | Generic | 55 | 54 | $4,999 |
| Metronidazole | Generic | 42 | 23 | $2,742 |
| Finasteride | Generic | 41 | 0 | $494 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 40 | 30 | $1,421 |
| Ketoconazole | Generic | 38 | 30 | $1,090 |
| Triamcinolone Acetonide | Generic | 32 | 28 | $299 |
Frequently asked questions
What is Dr. Beata Rydzik's medical specialty?
Dr. Beata Rydzik practices Dermatology Physician in Portland, OR.
Where does Dr. Beata Rydzik practice?
Dr. Beata Rydzik practices at 9427 Sw Barnes RD, Portland, OR 972256652. Office phone: 5032973440.
What is Dr. Beata Rydzik's NPI?
Dr. Beata Rydzik's National Provider Identifier (NPI) is 1457357576, issued by NPPES.
Does Dr. Beata Rydzik accept Medicare assignment?
Yes. Dr. Beata Rydzik accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Beata Rydzik commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99214); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.